首页 > 最新文献

International Journal of Pharmacy Practice最新文献

英文 中文
A global pharmacy family. 全球药房大家庭。
IF 1.8 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-02-15 DOI: 10.1093/ijpp/riad092
Christine Bond
{"title":"A global pharmacy family.","authors":"Christine Bond","doi":"10.1093/ijpp/riad092","DOIUrl":"10.1093/ijpp/riad092","url":null,"abstract":"","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":"1-2"},"PeriodicalIF":1.8,"publicationDate":"2024-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139570070","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A before-after study to evaluate the effect of pharmacy workflow redesign to improve pharmacy waiting time and reduce medication near misses in Malaysia. 在马来西亚开展一项前后对比研究,评估重新设计药房工作流程对改善药房等候时间和减少药物险情的影响。
IF 1.8 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-02-15 DOI: 10.1093/ijpp/riad083
Jerry Ee Siung Liew, Yew Chong Cheng, Nyet Ling Tai, Angeline Pereira, Vinoth Manivannan, Siok Luan Khoo, Woei Kheen Wong, Huey Kuen Lim, Shi Jing Ong, Nadia Bin Mohd Khairudin, Kristine Sheh Fuen Lee, Benjamin Chuan Ching Loh, Kai Loon Chong, Yee Leng Lee

Objectives: This study aimed to evaluate the effectiveness of workflow redesign (eaST system) on pharmacy waiting time and near-missed events. We also investigated other factors that may potentially affect these study outcomes.

Methods: A quasi-experimental (before-after) study design was adopted. Pre-intervention data were collected over 7 months (January-July 2017). Subsequently, the workflow redesign (eaST system) was implemented and the effect of the intervention (August 2017-February 2018) was evaluated. Univariate analysis was used to compare the differences between pre-intervention and post-intervention of pharmacy waiting time and near-missed events. Significant factors affecting study outcomes were analysed using linear regression analysis.

Key findings: A total of 210,530 prescriptions were analysed. The eaST system significantly increases the percentage of prescriptions dispensed within 30 min per day (median = 68 (interquartile range (IQR) = 41) vs. median = 93 (IQR = 33), P < 0.001) and reduced the mean percentage of near-missed events (mean = 50.71 (standard deviation (SD) = 23.95) vs. mean = 27.87 (SD = 12.23), P < 0.001). However, the eaST system's effects on related outcomes were conditional on a three-way interaction effect. The eaST system's effects on pharmacy waiting time were influenced by the number of prescriptions received and the number of PhIS server disruptions. Conversely, the eaST system's effects on near-missed events were influenced by the number of pharmacy personnel and number of controlled medications.

Conclusions: Overall, the eaST system improved the pharmacy waiting time and reduced near-missed events.

研究目的本研究旨在评估工作流程重新设计(eaST 系统)对药房等候时间和近乎失误事件的影响。我们还调查了可能影响这些研究结果的其他因素:方法:采用准实验(前后)研究设计。干预前的数据收集历时 7 个月(2017 年 1 月至 7 月)。随后,实施了工作流程重新设计(eaST 系统),并对干预效果进行了评估(2017 年 8 月至 2018 年 2 月)。采用单变量分析比较了干预前和干预后药房等待时间和近乎失误事件的差异。采用线性回归分析法对影响研究结果的重要因素进行了分析:共分析了 210,530 份处方。eaST 系统大幅提高了每天 30 分钟内配药的处方比例(中位数 = 68(四分位距 (IQR) = 41)对中位数 = 93(四分位距 (IQR) = 33),P < 0.001),并降低了近乎失误事件的平均比例(平均值 = 50.71(标准差 (SD) = 23.95)对平均值 = 27.87(标准差 = 12.23),P < 0.001)。然而,eaST 系统对相关结果的影响取决于三方交互效应。eaST 系统对药房等待时间的影响受收到的处方数量和 PhIS 服务器中断次数的影响。相反,eaST 系统对近乎失误事件的影响则受药房人员数量和受控药物数量的影响:总的来说,eaST 系统改善了药房的等待时间,减少了近乎失误事件。
{"title":"A before-after study to evaluate the effect of pharmacy workflow redesign to improve pharmacy waiting time and reduce medication near misses in Malaysia.","authors":"Jerry Ee Siung Liew, Yew Chong Cheng, Nyet Ling Tai, Angeline Pereira, Vinoth Manivannan, Siok Luan Khoo, Woei Kheen Wong, Huey Kuen Lim, Shi Jing Ong, Nadia Bin Mohd Khairudin, Kristine Sheh Fuen Lee, Benjamin Chuan Ching Loh, Kai Loon Chong, Yee Leng Lee","doi":"10.1093/ijpp/riad083","DOIUrl":"10.1093/ijpp/riad083","url":null,"abstract":"<p><strong>Objectives: </strong>This study aimed to evaluate the effectiveness of workflow redesign (eaST system) on pharmacy waiting time and near-missed events. We also investigated other factors that may potentially affect these study outcomes.</p><p><strong>Methods: </strong>A quasi-experimental (before-after) study design was adopted. Pre-intervention data were collected over 7 months (January-July 2017). Subsequently, the workflow redesign (eaST system) was implemented and the effect of the intervention (August 2017-February 2018) was evaluated. Univariate analysis was used to compare the differences between pre-intervention and post-intervention of pharmacy waiting time and near-missed events. Significant factors affecting study outcomes were analysed using linear regression analysis.</p><p><strong>Key findings: </strong>A total of 210,530 prescriptions were analysed. The eaST system significantly increases the percentage of prescriptions dispensed within 30 min per day (median = 68 (interquartile range (IQR) = 41) vs. median = 93 (IQR = 33), P < 0.001) and reduced the mean percentage of near-missed events (mean = 50.71 (standard deviation (SD) = 23.95) vs. mean = 27.87 (SD = 12.23), P < 0.001). However, the eaST system's effects on related outcomes were conditional on a three-way interaction effect. The eaST system's effects on pharmacy waiting time were influenced by the number of prescriptions received and the number of PhIS server disruptions. Conversely, the eaST system's effects on near-missed events were influenced by the number of pharmacy personnel and number of controlled medications.</p><p><strong>Conclusions: </strong>Overall, the eaST system improved the pharmacy waiting time and reduced near-missed events.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":"83-90"},"PeriodicalIF":1.8,"publicationDate":"2024-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139642050","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Practice pharmacists and their influence on prescribing in UK general practice: a cross-sectional study. 执业药师及其对英国全科执业处方的影响:一项横断面研究。
IF 1.8 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-02-15 DOI: 10.1093/ijpp/riad075
Mary Carter, Sarah Chapman, Philip Rogers, Margaret Watson

Objectives: At the time of the survey, just over 2000 pharmacists were employed in UK general practice. Little is known about their influence on prescribing, and more specifically, the extent of their use of Audit and Feedback (A&F), an evidence-based method for behaviour change. This study aimed to explore pharmacists' current influence on prescribing in UK general practice.

Methods: A cross-sectional, online survey was open to general practice pharmacists in England, Northern Ireland, Scotland, and Wales between 9 September 2021 and 31 October 2021. The survey comprised 36 items, informed by the literature, including multiple choice and free-text questions about pharmacist responsibilities, involvement in prescribing audits (including use of A&F), use of prescribing guidelines, beliefs about influence on prescribing, and access to training and support. Descriptive statistics and frequencies were generated, and parametric analyses were conducted.

Key findings: In total, 155 responses were received from pharmacists in diverse practice locations, with a wide range of practice pharmacist experience. The majority (80%, n = 121) conducted prescribing audits, but only 21% (n = 32) reported undertaking A&F. Most respondents (90%, n = 140) used guidelines to inform their work, and 75% (n = 116) would welcome training on influencing prescribing. Pharmacists using A&F were more likely to believe in their ability to influence prescribing and to acknowledge this activity as part of their role.

Conclusion: Despite substantial evidence of its effectiveness, A&F is under-used by practice pharmacists. An increased awareness and enablement of practice pharmacists in effective techniques might promote greater evidence-based prescribing in general practice.

目的:在调查的时候,刚刚超过2000名药剂师在英国全科执业。他们对处方的影响知之甚少,更具体地说,他们对审计和反馈(A&F)的使用程度知之甚少,审计和反馈是一种基于证据的行为改变方法。本研究旨在探讨药剂师目前对英国全科医生处方的影响。方法:在2021年9月9日至2021年10月31日期间,对英格兰、北爱尔兰、苏格兰和威尔士的全科药剂师进行横断面在线调查。该调查包括36个项目,由文献提供信息,包括多项选择和自由文本问题,涉及药剂师职责、参与处方审计(包括使用A&F)、使用处方指南、对处方影响的信念以及获得培训和支持的情况。生成描述性统计和频率,并进行参数分析。主要发现:总共收到了155份来自不同执业地点的药剂师的回复,他们具有广泛的执业药剂师经验。大多数(80%,n = 121)进行了处方审计,但只有21% (n = 32)报告进行了A&F审计。大多数受访者(90%,n = 140)使用指南来指导他们的工作,75% (n = 116)的受访者欢迎关于影响处方的培训。使用A&F的药剂师更有可能相信他们影响处方的能力,并承认这种活动是他们角色的一部分。结论:尽管有大量证据表明其有效性,但A&F未被执业药师充分利用。提高实践药师对有效技术的认识和支持可能会促进全科实践中更多的循证处方。
{"title":"Practice pharmacists and their influence on prescribing in UK general practice: a cross-sectional study.","authors":"Mary Carter, Sarah Chapman, Philip Rogers, Margaret Watson","doi":"10.1093/ijpp/riad075","DOIUrl":"10.1093/ijpp/riad075","url":null,"abstract":"<p><strong>Objectives: </strong>At the time of the survey, just over 2000 pharmacists were employed in UK general practice. Little is known about their influence on prescribing, and more specifically, the extent of their use of Audit and Feedback (A&F), an evidence-based method for behaviour change. This study aimed to explore pharmacists' current influence on prescribing in UK general practice.</p><p><strong>Methods: </strong>A cross-sectional, online survey was open to general practice pharmacists in England, Northern Ireland, Scotland, and Wales between 9 September 2021 and 31 October 2021. The survey comprised 36 items, informed by the literature, including multiple choice and free-text questions about pharmacist responsibilities, involvement in prescribing audits (including use of A&F), use of prescribing guidelines, beliefs about influence on prescribing, and access to training and support. Descriptive statistics and frequencies were generated, and parametric analyses were conducted.</p><p><strong>Key findings: </strong>In total, 155 responses were received from pharmacists in diverse practice locations, with a wide range of practice pharmacist experience. The majority (80%, n = 121) conducted prescribing audits, but only 21% (n = 32) reported undertaking A&F. Most respondents (90%, n = 140) used guidelines to inform their work, and 75% (n = 116) would welcome training on influencing prescribing. Pharmacists using A&F were more likely to believe in their ability to influence prescribing and to acknowledge this activity as part of their role.</p><p><strong>Conclusion: </strong>Despite substantial evidence of its effectiveness, A&F is under-used by practice pharmacists. An increased awareness and enablement of practice pharmacists in effective techniques might promote greater evidence-based prescribing in general practice.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":"69-75"},"PeriodicalIF":1.8,"publicationDate":"2024-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138440707","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Improving pharmaceutical practice in diabetes care using point-of-care glycated haemoglobin testing in the community pharmacy. 在社区药房使用护理点糖化血红蛋白检测改善糖尿病护理的药物实践。
IF 1.8 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-02-15 DOI: 10.1093/ijpp/riad072
Caroline Rocha Santana, Márcio Galvão Guimarães de Oliveira, Marianne Silveira Camargo, Pablo Maciel Brasil Moreira, Priscila Ribeiro de Castro, Erlan Canguçu Aguiar, Sóstenes Mistro

Objectives: To evaluate the use of point-of-care testing to detect new cases of diabetes mellitus at a Brazilian public community pharmacy.

Methods: This cross-sectional study included individuals without a previous diagnosis of diabetes mellitus who met the criteria for screening according to the Brazilian Diabetes Society, which were identified during their presence at a Brazilian public community pharmacy. The measurements of HbA1c were performed using a Cobas b101 device (Roche Diagnostics) and were categorized according to the following classification established by the Brazilian Society of Diabetes: HbA1c <5.7%, normal; HbA1c between 5.7% and 6.4%, pre-diabetes; and HbA1c >6.4%, new diagnosis of T2DM.

Key findings: One hundred and eight users met the inclusion criteria. The patients' mean age was 54.4 (± 15.4) years old, ranging from 22 to 80 years old. Eighty (74.1%) participants presented with glycated haemoglobin levels over the standard threshold, of which 58 (72.5%) were in the pre-diabetes range (glycated haemoglobin levels between 5.7% and 6.4%), and 22 (27.5%) had glycated haemoglobin levels >6.4%, which corresponds to a new diagnosis of type 2 diabetes mellitus.

Conclusions: The use of point-of-care glycated haemoglobin testing allowed community pharmacists at a Brazilian public community pharmacy to identify health system users with glycated haemoglobin alterations that corresponded to the pre-diabetes state or a new diagnosis of type 2 diabetes mellitus. This presented a good opportunity to refer these users to diabetes diagnosis and treatment services.

目的:评估在巴西公共社区药房使用护理点检测检测新糖尿病病例的情况。方法:这项横断面研究纳入了之前没有糖尿病诊断的符合巴西糖尿病协会筛查标准的个体,这些个体是在巴西公共社区药房就诊期间发现的。HbA1c的测量使用Cobas b101设备(Roche Diagnostics)进行,并根据巴西糖尿病协会制定的以下分类进行分类:HbA1c 6.4%,T2DM的新诊断。关键发现:108名用户符合纳入标准。患者的平均年龄为54.4(±15.4)岁,年龄在22-80岁之间。80名(74.1%)参与者的糖化血红蛋白水平超过标准阈值,其中58名(72.5%)处于糖尿病前期(糖化血红蛋白水平在5.7%至6.4%之间),22名(27.5%)参与者的血糖水平>6.4%,这对应于2型糖尿病的新诊断。结论:护理点糖化血红蛋白检测的使用使巴西公共社区药房的社区药剂师能够识别患有糖化血红蛋白改变的卫生系统使用者,这些改变与糖尿病前期状态或2型糖尿病的新诊断相对应。这为这些用户提供了一个很好的糖尿病诊断和治疗服务的机会。
{"title":"Improving pharmaceutical practice in diabetes care using point-of-care glycated haemoglobin testing in the community pharmacy.","authors":"Caroline Rocha Santana, Márcio Galvão Guimarães de Oliveira, Marianne Silveira Camargo, Pablo Maciel Brasil Moreira, Priscila Ribeiro de Castro, Erlan Canguçu Aguiar, Sóstenes Mistro","doi":"10.1093/ijpp/riad072","DOIUrl":"10.1093/ijpp/riad072","url":null,"abstract":"<p><strong>Objectives: </strong>To evaluate the use of point-of-care testing to detect new cases of diabetes mellitus at a Brazilian public community pharmacy.</p><p><strong>Methods: </strong>This cross-sectional study included individuals without a previous diagnosis of diabetes mellitus who met the criteria for screening according to the Brazilian Diabetes Society, which were identified during their presence at a Brazilian public community pharmacy. The measurements of HbA1c were performed using a Cobas b101 device (Roche Diagnostics) and were categorized according to the following classification established by the Brazilian Society of Diabetes: HbA1c <5.7%, normal; HbA1c between 5.7% and 6.4%, pre-diabetes; and HbA1c >6.4%, new diagnosis of T2DM.</p><p><strong>Key findings: </strong>One hundred and eight users met the inclusion criteria. The patients' mean age was 54.4 (± 15.4) years old, ranging from 22 to 80 years old. Eighty (74.1%) participants presented with glycated haemoglobin levels over the standard threshold, of which 58 (72.5%) were in the pre-diabetes range (glycated haemoglobin levels between 5.7% and 6.4%), and 22 (27.5%) had glycated haemoglobin levels >6.4%, which corresponds to a new diagnosis of type 2 diabetes mellitus.</p><p><strong>Conclusions: </strong>The use of point-of-care glycated haemoglobin testing allowed community pharmacists at a Brazilian public community pharmacy to identify health system users with glycated haemoglobin alterations that corresponded to the pre-diabetes state or a new diagnosis of type 2 diabetes mellitus. This presented a good opportunity to refer these users to diabetes diagnosis and treatment services.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":"46-51"},"PeriodicalIF":1.8,"publicationDate":"2024-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71481409","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Has a national recruitment scheme created a positive intervention for Black, Asian or other Minority Ethnic pharmacy trainees? 国家招聘计划是否为黑人、亚裔或其他少数民族药房学员创造了积极的干预措施?
IF 1.8 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2023-12-19 DOI: 10.1093/ijpp/riad060
Atif Shamim, Khalid Khan, Muhammad Faisal, Gail Fleming, Helen Porter, Hadar Zaman

Objectives: A National Recruitment Scheme (NRS) for Pharmacy trainees was introduced in England and Wales in 2017, standardising recruitment processes on behalf of employers and with the aim of reducing bias for candidates applying to training posts within the National Health Service (NHS). This research attempted to identify whether the introduction of the NRS had an impact on the recruitment of Black, Asian, or other Minority Ethnic applicants into the most sought-after posts within the Scheme (hospital posts).

Methods: An observational study was undertaken. Anonymised pharmacist trainee recruitment data between the cohort intakes of 2015-16 and 2020-21 was obtained from the pharmacy regulator the General Pharmaceutical Council and a comparison of proportional representations of ethnicities was undertaken, to ascertain whether a greater proportion of applicants from minority backgrounds attained the most sought-after posts in the NHS after the NRS was introduced. A robust generalised linear model was then used to analyse the data using binomial as the variance function and logit as a link function, where the proportion of hospital recruitment was an outcome with a two-way interaction between intervention and ethnicity after adjusting for overall proportion.

Key findings: The statistical analysis of 18 283 pharmacy trainees in total, of whom 4446 were in hospital, shows a significant overall impact of intervention, with a significant positive change in the proportions of Asian-Pakistani applicants (P-value < 0.001) and Black-African applicants (P-value < 0.001) recruited to hospital posts.

Conclusions: Since the introduction of the NRS there has been a statistically significant impact on the correlation between the overall number of Black, Asian or other Minority Ethnic applicants and their proportion in hospital. That is, not only is the makeup of the hospital cohort increasingly reflecting the diversity of the overall cohort, but also a larger percentage of each ethnic cohort is attaining hospital training places.

目标:2017年,英格兰和威尔士推出了一项针对药房实习生的国家招聘计划(NRS),代表雇主标准化招聘流程,旨在减少申请国家医疗服务体系(NHS)培训职位的候选人的偏见。这项研究试图确定NRS的引入是否会影响黑人、亚裔或其他少数族裔申请人进入该计划中最受欢迎的职位(医院职位)。方法:进行一项观察性研究。2015-16年和2020-21年队列招生期间的匿名药剂师实习生招聘数据来自药房监管机构总制药委员会,并对种族比例代表进行了比较,以确定在引入NRS后,是否有更大比例的少数族裔背景的申请人获得了NHS中最受欢迎的职位。然后使用一个稳健的广义线性模型来分析数据,使用二项式作为方差函数,logit作为联系函数,其中医院招聘的比例是在调整总体比例后,干预和种族之间双向互动的结果。主要发现:对总共18283名药学实习生(其中4446人在医院)的统计分析显示,干预措施的总体影响显著,招募到医院岗位的亚裔巴基斯坦申请人(P值<0.001)和黑人非洲申请人(P价值<0.001)的比例发生了显著的正变化。结论:自NRS引入以来,黑人、亚裔或其他少数民族申请者的总人数与其住院比例之间的相关性受到了统计上的显著影响。也就是说,不仅医院队列的构成越来越反映出整个队列的多样性,而且每个种族队列中有更大比例的人获得了医院培训名额。
{"title":"Has a national recruitment scheme created a positive intervention for Black, Asian or other Minority Ethnic pharmacy trainees?","authors":"Atif Shamim, Khalid Khan, Muhammad Faisal, Gail Fleming, Helen Porter, Hadar Zaman","doi":"10.1093/ijpp/riad060","DOIUrl":"10.1093/ijpp/riad060","url":null,"abstract":"<p><strong>Objectives: </strong>A National Recruitment Scheme (NRS) for Pharmacy trainees was introduced in England and Wales in 2017, standardising recruitment processes on behalf of employers and with the aim of reducing bias for candidates applying to training posts within the National Health Service (NHS). This research attempted to identify whether the introduction of the NRS had an impact on the recruitment of Black, Asian, or other Minority Ethnic applicants into the most sought-after posts within the Scheme (hospital posts).</p><p><strong>Methods: </strong>An observational study was undertaken. Anonymised pharmacist trainee recruitment data between the cohort intakes of 2015-16 and 2020-21 was obtained from the pharmacy regulator the General Pharmaceutical Council and a comparison of proportional representations of ethnicities was undertaken, to ascertain whether a greater proportion of applicants from minority backgrounds attained the most sought-after posts in the NHS after the NRS was introduced. A robust generalised linear model was then used to analyse the data using binomial as the variance function and logit as a link function, where the proportion of hospital recruitment was an outcome with a two-way interaction between intervention and ethnicity after adjusting for overall proportion.</p><p><strong>Key findings: </strong>The statistical analysis of 18 283 pharmacy trainees in total, of whom 4446 were in hospital, shows a significant overall impact of intervention, with a significant positive change in the proportions of Asian-Pakistani applicants (P-value < 0.001) and Black-African applicants (P-value < 0.001) recruited to hospital posts.</p><p><strong>Conclusions: </strong>Since the introduction of the NRS there has been a statistically significant impact on the correlation between the overall number of Black, Asian or other Minority Ethnic applicants and their proportion in hospital. That is, not only is the makeup of the hospital cohort increasingly reflecting the diversity of the overall cohort, but also a larger percentage of each ethnic cohort is attaining hospital training places.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":"638-645"},"PeriodicalIF":1.8,"publicationDate":"2023-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71481408","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Brave new pharmaceuticals world. 勇敢的医药新世界
IF 1.8 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2023-12-19 DOI: 10.1093/ijpp/riad066
Albert Wertheimer
{"title":"Brave new pharmaceuticals world.","authors":"Albert Wertheimer","doi":"10.1093/ijpp/riad066","DOIUrl":"10.1093/ijpp/riad066","url":null,"abstract":"","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":"569-570"},"PeriodicalIF":1.8,"publicationDate":"2023-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10068283","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Economic evaluations of adult critical care pharmacy services: a scoping review. 成人重症监护药学服务的经济评估:范围界定审查。
IF 1.8 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2023-12-19 DOI: 10.1093/ijpp/riad049
Alex Crosby, Jennifer K Jennings, Anna T Mills, Jonathan Silcock, Richard S Bourne

Objectives: To summarise the extent and type of evidence available regarding economic evaluations of adult critical care pharmacy services in the context of UK practice.

Methods: A literature search was conducted in eight electronic databases and hand searching of full-text reference lists. Of 2409 journal articles initially identified, 38 were included in the final review. Independent literature review was undertaken by two investigators in a two-step process against the inclusion and exclusion criteria; title and abstract screening were followed by full-text screening. Included studies were taken from high-income economy countries that contained economic data evaluating any key aspect of adult critical care pharmacy services. Grey literature and studies that could not be translated into the English language were excluded.

Results: The majority were before-and-after studies (18, 47%) or other observational studies (17, 45%), and conducted in North America (25, 66%). None of the included studies were undertaken in the UK. Seven studies (18%) included cost-benefit analysis; all demonstrated positive cost-benefit values for clinical pharmacist activities.

Conclusions: Further high-quality primary research focussing on the economic evaluation of UK adult critical care pharmacy services is needed, before undertaking a future systematic review. There is an indication of a cost-benefit value for critical care pharmacist activities. The lack of UK-based economic evaluations is a limitation to further development and standardisation of critical care pharmacy services nationally.

目的总结英国成人重症监护药学服务经济评估的证据范围和类型:方法: 在八个电子数据库中进行了文献检索,并对参考文献目录全文进行了人工检索。在初步确定的 2409 篇期刊论文中,38 篇被纳入最终评审。两名研究人员根据纳入和排除标准分两步进行了独立的文献综述;标题和摘要筛选之后是全文筛选。纳入的研究均来自高收入经济体国家,其中包含评估成人重症监护药学服务任何关键方面的经济数据。灰色文献和无法翻译成英文的研究被排除在外:大部分是前后对比研究(18 项,占 47%)或其他观察性研究(17 项,占 45%),在北美进行(25 项,占 66%)。没有一项研究是在英国进行的。七项研究(18%)包含成本效益分析;所有研究均显示临床药师活动具有积极的成本效益价值:结论:在未来进行系统性回顾之前,需要进一步开展以英国成人重症监护药学服务经济评估为重点的高质量初级研究。有迹象表明重症监护药剂师活动具有成本效益价值。缺乏基于英国的经济评估是进一步发展和规范全国重症监护药学服务的限制因素。
{"title":"Economic evaluations of adult critical care pharmacy services: a scoping review.","authors":"Alex Crosby, Jennifer K Jennings, Anna T Mills, Jonathan Silcock, Richard S Bourne","doi":"10.1093/ijpp/riad049","DOIUrl":"10.1093/ijpp/riad049","url":null,"abstract":"<p><strong>Objectives: </strong>To summarise the extent and type of evidence available regarding economic evaluations of adult critical care pharmacy services in the context of UK practice.</p><p><strong>Methods: </strong>A literature search was conducted in eight electronic databases and hand searching of full-text reference lists. Of 2409 journal articles initially identified, 38 were included in the final review. Independent literature review was undertaken by two investigators in a two-step process against the inclusion and exclusion criteria; title and abstract screening were followed by full-text screening. Included studies were taken from high-income economy countries that contained economic data evaluating any key aspect of adult critical care pharmacy services. Grey literature and studies that could not be translated into the English language were excluded.</p><p><strong>Results: </strong>The majority were before-and-after studies (18, 47%) or other observational studies (17, 45%), and conducted in North America (25, 66%). None of the included studies were undertaken in the UK. Seven studies (18%) included cost-benefit analysis; all demonstrated positive cost-benefit values for clinical pharmacist activities.</p><p><strong>Conclusions: </strong>Further high-quality primary research focussing on the economic evaluation of UK adult critical care pharmacy services is needed, before undertaking a future systematic review. There is an indication of a cost-benefit value for critical care pharmacist activities. The lack of UK-based economic evaluations is a limitation to further development and standardisation of critical care pharmacy services nationally.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":"574-584"},"PeriodicalIF":1.8,"publicationDate":"2023-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10041891","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of a community pharmacy led antibiotic amnesty in the Midlands region of England. 英格兰中部地区由社区药房主导的抗生素大赦的影响。
IF 1.8 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2023-12-19 DOI: 10.1093/ijpp/riad040
Marco G Ercolani, Rakhi Aggarwal, Angela Barker, Donna Cooper, Conor Jamieson

Objectives: Antimicrobial resistance is a recognised threat to human health and may be driven by the unsafe disposal of antibiotics via domestic waste streams, contaminating the environment. A community pharmacy based antibiotic amnesty could address this.

Methods: We evaluated the impact of an antibiotic amnesty promoting the return of unused antibiotics to community pharmacies in the Midlands region of England during World Antibiotic Awareness Week in November 2021.

Results: Two hundred and thirty nine pharmacies participated voluntarily and held amnesty conversations with 7399 people, 369 part used and 126 full packs of antibiotics were returned.

Conclusions: This is an important public health initiative that could be replicated more widely.

目标:抗菌药耐药性是公认的人类健康威胁,其产生原因可能是通过家庭废物流不安全地处理抗生素,从而污染环境。以社区药房为基础的抗生素大赦可以解决这一问题:我们评估了 2021 年 11 月世界抗生素宣传周期间在英格兰中部地区开展的抗生素大赦活动对促进社区药房交回未使用抗生素的影响:239 家药房自愿参与,与 7399 人进行了大赦谈话,369 人退还了部分使用的抗生素,126 人退还了整包抗生素:结论:这是一项重要的公共卫生活动,可以在更大范围内推广。
{"title":"Impact of a community pharmacy led antibiotic amnesty in the Midlands region of England.","authors":"Marco G Ercolani, Rakhi Aggarwal, Angela Barker, Donna Cooper, Conor Jamieson","doi":"10.1093/ijpp/riad040","DOIUrl":"10.1093/ijpp/riad040","url":null,"abstract":"<p><strong>Objectives: </strong>Antimicrobial resistance is a recognised threat to human health and may be driven by the unsafe disposal of antibiotics via domestic waste streams, contaminating the environment. A community pharmacy based antibiotic amnesty could address this.</p><p><strong>Methods: </strong>We evaluated the impact of an antibiotic amnesty promoting the return of unused antibiotics to community pharmacies in the Midlands region of England during World Antibiotic Awareness Week in November 2021.</p><p><strong>Results: </strong>Two hundred and thirty nine pharmacies participated voluntarily and held amnesty conversations with 7399 people, 369 part used and 126 full packs of antibiotics were returned.</p><p><strong>Conclusions: </strong>This is an important public health initiative that could be replicated more widely.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":"650-652"},"PeriodicalIF":1.8,"publicationDate":"2023-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10070740","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A nationwide survey of methods and barriers to adverse drug reaction monitoring and reporting among hospital pharmacists in Thailand. 关于泰国医院药剂师监测和报告药物不良反应的方法和障碍的全国性调查。
IF 1.8 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2023-12-19 DOI: 10.1093/ijpp/riad051
Narumol Jarernsiripornkul, Sasina Kayrash, Prangwalai Homket, Warisara Srisuriyachanchai

Objectives: To explore the methods of adverse drug reaction identification and monitoring used by hospital pharmacists in all regions of Thailand, to explore barriers to and pharmacists' attitudes towards adverse drug reaction monitoring and reporting, and to assess the factors related to these aspects.

Methods: Pharmacists in 480 hospitals in Thailand were selected by stratified sampling. Self-administered questionnaires were sent by post and pharmacists returned completed questionnaires via QR code.

Key findings: In total, pharmacists at 286 hospitals returned the questionnaire (response rate = 59.6%). The most common adverse drug reaction (ADR) monitoring methods were the spontaneous reporting system (SRS), which was used by 100% of respondents, followed by high alert drug lists (73.1%) and routine adverse drug reaction monitoring (64.0%). The most frequently used methods of adverse drug reaction prevention were providing drug allergy card and recording allergy history in database. The major barrier to adverse drug reaction monitoring and reporting among respondents was uncertainty about whether the suspected drug caused the reaction (49.3%). Pharmacists had a good attitude towards adverse drug reaction monitoring and reporting (60.5%). Longer work experience (≥10 years) was negatively related with good attitudes towards adverse drug reaction monitoring and reporting (OR = 0.535, P = 0.040), whereas higher education level was positively related (OR = 2.201, P = 0.025).

Conclusions: Spontaneous reporting system is the main method used for adverse drug reaction monitoring and reporting among hospital pharmacists in Thailand. Pharmacists had good attitudes towards adverse drug reaction monitoring and reporting, however, barriers remain.

目的探讨泰国各地区医院药剂师使用的药物不良反应识别和监测方法,探讨药剂师对药物不良反应监测和报告的障碍和态度,并评估与这些方面相关的因素:方法:通过分层抽样的方式选取了泰国 480 家医院的药剂师。方法:通过分层抽样的方式选取了泰国 480 家医院的药剂师,并通过邮寄的方式发送了自填问卷,药剂师通过二维码返回了填写完毕的问卷:共有 286 家医院的药剂师返回了问卷(回复率 = 59.6%)。最常用的药物不良反应(ADR)监测方法是自发报告系统(SRS),100%的受访者使用该系统,其次是高度警戒药物清单(73.1%)和常规药物不良反应监测(64.0%)。最常用的药物不良反应预防方法是提供药物过敏卡和在数据库中记录过敏史。受访者监测和报告药物不良反应的主要障碍是不确定可疑药物是否导致不良反应(49.3%)。药剂师对监测和报告药物不良反应的态度良好(60.5%)。较长的工作经验(≥10 年)与对药品不良反应监测和报告的良好态度呈负相关(OR = 0.535,P = 0.040),而较高的教育水平与之呈正相关(OR = 2.201,P = 0.025):自发报告系统是泰国医院药剂师监测和报告药品不良反应的主要方法。药剂师对药物不良反应监测和报告的态度良好,但仍存在障碍。
{"title":"A nationwide survey of methods and barriers to adverse drug reaction monitoring and reporting among hospital pharmacists in Thailand.","authors":"Narumol Jarernsiripornkul, Sasina Kayrash, Prangwalai Homket, Warisara Srisuriyachanchai","doi":"10.1093/ijpp/riad051","DOIUrl":"10.1093/ijpp/riad051","url":null,"abstract":"<p><strong>Objectives: </strong>To explore the methods of adverse drug reaction identification and monitoring used by hospital pharmacists in all regions of Thailand, to explore barriers to and pharmacists' attitudes towards adverse drug reaction monitoring and reporting, and to assess the factors related to these aspects.</p><p><strong>Methods: </strong>Pharmacists in 480 hospitals in Thailand were selected by stratified sampling. Self-administered questionnaires were sent by post and pharmacists returned completed questionnaires via QR code.</p><p><strong>Key findings: </strong>In total, pharmacists at 286 hospitals returned the questionnaire (response rate = 59.6%). The most common adverse drug reaction (ADR) monitoring methods were the spontaneous reporting system (SRS), which was used by 100% of respondents, followed by high alert drug lists (73.1%) and routine adverse drug reaction monitoring (64.0%). The most frequently used methods of adverse drug reaction prevention were providing drug allergy card and recording allergy history in database. The major barrier to adverse drug reaction monitoring and reporting among respondents was uncertainty about whether the suspected drug caused the reaction (49.3%). Pharmacists had a good attitude towards adverse drug reaction monitoring and reporting (60.5%). Longer work experience (≥10 years) was negatively related with good attitudes towards adverse drug reaction monitoring and reporting (OR = 0.535, P = 0.040), whereas higher education level was positively related (OR = 2.201, P = 0.025).</p><p><strong>Conclusions: </strong>Spontaneous reporting system is the main method used for adverse drug reaction monitoring and reporting among hospital pharmacists in Thailand. Pharmacists had good attitudes towards adverse drug reaction monitoring and reporting, however, barriers remain.</p>","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":"625-632"},"PeriodicalIF":1.8,"publicationDate":"2023-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9835379","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Time to treat the climate and nature crisis as one indivisible global health emergency†. 是时候将气候和自然危机视为一个不可分割的全球卫生紧急事件了†。
IF 1.8 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2023-12-19 DOI: 10.1093/ijpp/riad069
Kamran Abbasi, Parveen Ali, Virginia Barbour, Thomas Benfield, Kirsten Bibbins-Domingo, Stephen Hancocks, Richard Horton, Laurie Laybourn-Langton, Robert Mash, Peush Sahni, Wadeia Mohammad Sharief, Paul Yonga, Chris Zielinski
{"title":"Time to treat the climate and nature crisis as one indivisible global health emergency†.","authors":"Kamran Abbasi, Parveen Ali, Virginia Barbour, Thomas Benfield, Kirsten Bibbins-Domingo, Stephen Hancocks, Richard Horton, Laurie Laybourn-Langton, Robert Mash, Peush Sahni, Wadeia Mohammad Sharief, Paul Yonga, Chris Zielinski","doi":"10.1093/ijpp/riad069","DOIUrl":"10.1093/ijpp/riad069","url":null,"abstract":"","PeriodicalId":14284,"journal":{"name":"International Journal of Pharmacy Practice","volume":" ","pages":"571-573"},"PeriodicalIF":1.8,"publicationDate":"2023-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50161592","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International Journal of Pharmacy Practice
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1